在非小细胞肺癌患者接受新辅助化疗后,调控性T细胞的空间结构发生变化

Siqi Cai1, Miaoqing Zhao2, Guanqun Yang1

  • 1Shandong University Cancer Center, Shandong University, Jinan, Shandong, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

概括

新辅助化疗增加了非小细胞肺癌 (NSCLC) 的调节性T细胞 (Tregs) 和CD8+T细胞,改善了治疗反应和无复发生存率. 了解Treg空间动态有助于为NSCLC患者提供个性化免疫疗法.